24-week post-therapy factors | Univariate analyses | Multivariate analyses | ||
---|---|---|---|---|
 | 95% CI of β (β) | p values | 95% CI of β (β) | p values |
Male, yes | − 0.2028 to 1.232 (0.515) | 0.158 |  |  |
Age, (years) | − 0.041 to 0.015 (− 0.013) | 0.354 |  |  |
BMI (kg/m2) | 0.184–0.358 (0.271) |  < 0.001 | 0.094–0.335 (0.215) | 0.001 |
ALT (U/L) | 0.049–0.094 (0.071) |  < 0.001 | 0.018–0.078 (0.048) | 0.002 |
eGFR (mL/min/1.73 m2) | − 0.0024 to 0.025 (0.011) | 0.102 |  |  |
TG (mg/dL) | 0.006–0.014 (0.01) |  < 0.001 | 0.000–0.01 (0.005) | 0.057 |
TC (mg/dL) | − 0.015 to 0.004 (− 0.005) | 0.271 |  |  |
Adiponectin (μg/mL) | − 0.22 to 0.064 (− 0.078) | 0.283 |  |  |
Uric acid (mg/dL) | − 0.1046 to 0.466 (0.181) | 0.212 |  |  |
NLR | − 6.116 to 4.889 (− 0.613) | 0.391 |  |  |
Platelet (103/uL) | − 0.013 to 0.00 (− 0.007) | 0.059 | − 0.013 to 0.002 (− 0.005) | 0.145 |
Liver cirrhosis, yes | 0.12–1.789 (0.954) | 0.025 | − 1.000 to 1.253 (0.126) | 0.825 |
Fibrosis-4 score | − 0.069 to 0.263 (0.097) | 0.252 |  |  |
Ferritin (ng/mL) | 0.001–0.004 (0.002) | 0.001 | 0.000–0.003 (0.001) | 0.092 |
IFNL3-rs12979860 CC genotype, yes | − 1.875 to 0.318 (− 0.778) | 0.163 |  |  |